Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net income	$ 3,998	$ 2,569
Adjustments to reconcile net income to net cash provided by operations:
Depreciation and amortization	678	726
Provision for loan losses	561	1,142
Amortization of premium on securities, net	409	465
Amortization of discount on subordinated notes	31	30
Losses on sales and write-downs of other real estate, net	334	581
Gains on sales of investment securities	(60)	(69)
Increase in value of life insurance contracts	(202)	(200)
Income from life insurance death benefit	(642)
Stock compensation expense	315	148
Originations of loans held for sale	(25,394)	(33,611)
Proceeds from sales of loans held for sale	27,405	33,392
Gains on sales of loans held for sale	(509)	(690)
Changes in assets and liabilities:
Accrued income	382	(392)
Other assets	(439)	(53)
Deferred taxes, net	(208)	(123)
Accrued interest payable	35	(18)
Other liabilities	558	343
Net cash flows provided by operating activities	7,252	4,240
Cash flows from investing activities:
Net increase in federal funds sold	(14)	(138)
Purchases of available for sale securities	(900)	(23,403)
Sales, maturities, and calls of available for sale securities	10,071	20,544
Redemptions (purchase) of restricted equity securities, net	130	(158)
Net increase in loans	(28,291)	(27,248)
Proceeds from sales of other real estate	1,719	988
Purchases of bank owned life insurance		(1,000)
Death benefit from bank owned life insurance	1,316
Purchases of property and equipment	(684)	(292)
Net cash flows used in investing activities	(16,653)	(30,707)
Cash flows from financing activities:
Net increase in noninterest-bearing deposits	10,588	15,602
Net increase in interest-bearing deposits	5,265	10,870
Net increase (decrease) in FHLB borrowings	(3,084)	3,028
Net increase (decrease) in other borrowings	(1,475)	441
Distribution of equity of non-controlling interest	(204)
Common stock cash dividends paid	(697)
Exercise of stock options	85	31
Net settlement of restricted stock and cash in lieu of fractional shares	(20)	(20)
Net cash flows provided by financing activities	10,458	29,952
Net increase in cash and cash equivalents	1,057	3,485
Cash and cash equivalents, beginning	21,714	18,229
Cash and cash equivalents, ending	22,771	21,714
Supplemental disclosure of cash flow information:
Cash payments for interest	3,665	3,064
Cash payments for income taxes	1,245	1,461
Supplemental disclosure of noncash investing and financing activities:
Transfer from loans to other real estate owned	697	1,024
Change in unrealized gains and losses on available for sale securities	$ (848)	$ (94)